THE WOOF OF WALL STREET

[DewmBoom]

$BIEL: AN EARLY RETIREMENT STOCK-TAKE A READ

Below is a brief Summary for Investors. Dewmboom is an investor in Biel. Dewmboom is also a user of the Actipatch. As a matter of fact, I am using one on my shoulder after a Volleyball play yesterday.

FDA CLEARANCE

Biel's Actipatch was cleared in February by the FDA for OVER THE COUNTER (OTC) sale in the USA without a prescription. It is the only pulsed electromagnetic field device ever to be cleared by the FDA for the treatment of chronic pain that includes knee and heel pain. The Actipatch is cleared overseas but never got an FDA clearance until recently after many many years of trying.

https://www.accessdata.fda.gov/cdrh_docs/pdf15/k152432.pdf

CLINICAL TRIALS

OXFORD UNIVERSITY is completing a clinical trial for backpain. Biel also collected positive data from over 15,000 patients on backpain and presented to the FDA. When the FDA sees the clinical trial results, it will clear the product for general use in the US. The Oxdord study should be released any time.

https://clinicaltrials.gov/ct2/show/NCT02601807

Recenlty, Biel has also started a clincial trial for migraine with a potential to enter this 16 billion dollar business.

https://finance.yahoo.com/news/bioelectronics-announces-independent-migraine-clinical-123000938.html

https://clinicaltrials.gov/ct2/show/NCT03166046?term=ACTIPATCH+MIGRAINES&rank=1

Biel is also performing another clinical trial on the Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal Pain

https://clinicaltrials.gov/ct2/show/NCT02974023?term=pain+gear&rank=1

PRODUCT SALE

The Actipatch is currently sold in many countries around the world, particularly UK, Canada, Italy and Australia, besides other. to see a list of distributors you can to: www.actipatch.com
Most importantly, the Actipatch has become available on Amazon and tryactipatch.com for $9.95 as a trial for 7 days and $29.95 with 720 hours of use with an on/off switch for US customers.

The company plans to launch the product at Walgreens, Walmart, CVS and others starting in September. The compnay just completed a new enclosure look that complies with the FDA, and plans to put its products in stores in the US starting in September. Biel just announced expanding its product presence in the UK to TESCO.

About Tesco

Tesco PLC, (www.tesco.com) is a British multi-national company that specializes in the merchandise and grocery retail chain markets. It is the third largest retailer in the world, measured by profits and has over 3,000 stores in the U.K. alone. Founded in 1919, Tesco has diversified its offerings since the 1990's and is now present in 8 countries across Asia and Europe. As of 2016/2017, Tesco reported revenue of $72 billion.

https://finance.yahoo.com/news/bioelectronics-expands-tesco-uk-market-153126760.html

Biel generated a Revenue of about 2.1 million dollars with a gross profit of 1.25 million dollars in 2016.

http://www.otcmarkets.com/financialReportViewer?symbol=BIEL&id=168651

HOW DOES IT WORK

The Actipatch is different than anything availale in the market place. There are numerous TENS products sold by various companines, but there is only one and only one patented technology that is sold OTC named Actipatch. The Actipatch is a pulsed electromagnatic field device that pulsed at a 1000 hz (1000 times per second) with very very low power. The Actipatch is a drug free, side effects free, sensation free that has the potential to minimize and treat pain and reduce the depedency on opioids, which is a national epidemic.

To understand the technology and its principle of operation, BIEL released a youtube presentation explaining the process. Be patient and listen to the presentation if you are interested in this technology.

INTELLECTUAL PROPERTY

BIEL owns a huge patent portfolio and no other entity can sell a similar device without a patent infringement. This gives Biel a huge advantage.

http://patents.justia.com/assignee/bioelectronics-corp

SHARE STRUCTURE

BIEL, over the years, used dilution as a primary mechanism for funding its opartion. They never ever done a reverse split. As a matter of fact, they are a very very unique company in their financial model and they used it successfully. One huge benefit of that model is that they managed to reach this point with just over 10 million dollars in debt. A typical company reaching this milestone if ever, they will be over 200 million dollars in debt. The recent clinical trial on migraine headache with a possibility to make the product available OTC is huge by itself.

BIEL has an AS of 20 billion shares and an OS of 17.3 billion shares. Since Q4/2016, 20 billion shares were traded at an average price of 0.001 and a trading amount of 20 million dollars. In Q1/2017 alone, 11.5 billion shares traded with a dollar amount of over 15 million dollars. When people hear about the share count, they get scared due to the high number of shares, but really the market value is a peanut money and the debt amount is peanut relative to the accomplishement and value of the company. It is the share count and share price combined is what count and not simply one at a time. Investors should appreciate the fact that BIEL never ever diluted for many many years.


SUMMARY


BIEL has an unbelievable potential to become a multi billion dollar company, but it needs investors and not traders. BIEL accomplished a huge milestone and finally made it to the US market OTC with the FDA clearance. If you invest in Biel, at least give it a year and don't be a flipper. This is a real company with real products to reduce and/or heal pain and reduce dependancy on opioids and other pain killers.